Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Berchuck

Showing results (151-160 of 191) with videos related to

Pageof 20
Sort By:
Gynecologic Oncology|September 1, 1990
High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancerE J Shpall, D Clarke-Pearson, J T Soper, et al.
Experimental Cell Research|August 1, 1993
Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cellsY J Lidor, F J Xu, O Martínez-Maza, et al.
Gynecologic Oncology|October 1, 1995
Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic massesR P Woolas, M R Conaway, F Xu, et al.
American Journal of Obstetrics and Gynecology|April 1, 1990
Heterogeneity of antigen expression in advanced epithelial ovarian cancerA Berchuck, G J Olt, A P Soisson, et al.
Cancer Research|March 15, 1993
A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locusI J Jacobs, S A Smith, R W Wiseman, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 11, 1992
p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistryB J Kerns, P A Jordan, M B Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance proceduresF J Xu, Y H Yu, L Daly, et al.
British Journal of Cancer|July 16, 2009
MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibitionX Ding, A B Mohd, Z Huang, et al.
International Journal of Cancer|February 1, 1993
Antibody-induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185F Xu, R Lupu, G C Rodriguez, et al.
Journal of the National Cancer Institute|September 15, 1993
Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancerM F Kohler, J R Marks, R W Wiseman, et al.
Pageof 20

Showing results (151-160 of 191) with videos related to

Sort By:
Pageof 20
Gynecologic Oncology|September 1, 1990
High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancerE J Shpall, D Clarke-Pearson, J T Soper, et al.
Experimental Cell Research|August 1, 1993
Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cellsY J Lidor, F J Xu, O Martínez-Maza, et al.
Gynecologic Oncology|October 1, 1995
Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic massesR P Woolas, M R Conaway, F Xu, et al.
American Journal of Obstetrics and Gynecology|April 1, 1990
Heterogeneity of antigen expression in advanced epithelial ovarian cancerA Berchuck, G J Olt, A P Soisson, et al.
Cancer Research|March 15, 1993
A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locusI J Jacobs, S A Smith, R W Wiseman, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 11, 1992
p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistryB J Kerns, P A Jordan, M B Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance proceduresF J Xu, Y H Yu, L Daly, et al.
British Journal of Cancer|July 16, 2009
MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibitionX Ding, A B Mohd, Z Huang, et al.
International Journal of Cancer|February 1, 1993
Antibody-induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185F Xu, R Lupu, G C Rodriguez, et al.
Journal of the National Cancer Institute|September 15, 1993
Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancerM F Kohler, J R Marks, R W Wiseman, et al.
Pageof 20